◆英語タイトル：Neovasc Inc (NVC) - Financial and Strategic SWOT Analysis Review
Neovasc Inc (Neovasc) is a medical device manufacturing company that manufactures, develops, and sells cardiovascular disease products. The company’s products include Neovasc reducer, Neovasc tiara, and Neovasc tissue products. Its Neovasc tiara is a novel transcatheter device that is designed for treating mitral valve disease and mitral regurgitation and a condition that is often severe and can lead to heart failure and death. Neovasc’ Neovasc reducer is used for the treating refractory angina. The company’s reducer procedure uses standard catheter-based techniques. It has its operations in Canada and the US. Neovasc is headquartered in Richmond, British Columbia, Canada.
Neovasc Inc Key Recent Developments
Mar 11,2021: Neovasc Announces Fourth Quarter and Fiscal Year 2020 Financial Results
Feb 12,2021: Neovasc Announces Closing of US$72 Million Registered Direct Offering of Common Shares Priced At-The-Market
Feb 10,2021: Neovasc Announces US$72 Million Registered Direct Offering Priced At-The-Market
Jan 04,2021: Neovasc Announces Participation in H.C. Wainwright BioConnect 2021 Virtual Conference
Nov 05,2020: Neovasc announces third quarter financial results
This comprehensive SWOT profile of Neovasc Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Neovasc Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Neovasc Inc – Key Information
Neovasc Inc – Overview
Neovasc Inc – Key Employees
Neovasc Inc – Key Employee Biographies
Neovasc Inc – Key Operational Heads
Neovasc Inc – Major Products and Services
Neovasc Inc – History
Neovasc Inc – Company Statement
Neovasc Inc – Locations And Subsidiaries
Other Locations & Subsidiaries
Section 2 – Company Analysis
Neovasc Inc – Business Description
Neovasc Inc – Corporate Strategy
Neovasc Inc – SWOT Analysis
SWOT Analysis – Overview
Neovasc Inc – Strengths
Neovasc Inc – Weaknesses
Neovasc Inc – Opportunities
Neovasc Inc – Threats
Neovasc Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Neovasc Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Neovasc Inc, Key Information
Neovasc Inc, Key Ratios
Neovasc Inc, Share Data
Neovasc Inc, Major Products and Services
Neovasc Inc, History
Neovasc Inc, Key Employees
Neovasc Inc, Key Employee Biographies
Neovasc Inc, Key Operational Heads
Neovasc Inc, Other Locations
Neovasc Inc, Subsidiaries
Neovasc Inc, Key Competitors
Neovasc Inc, SWOT Analysis
Neovasc Inc, Ratios based on current share price
Neovasc Inc, Annual Ratios
Neovasc Inc, Interim Ratios
Capital Market Ratios
- AltaGas Ltd (ALA)：石油・ガス：M&Aディール及び事業提携情報
Summary AltaGas Ltd (AltaGas) is an energy utility. The company undertakes activities related to extraction, transmission, distribution and storage of natural gas. AltaGas generates electricity utilizing diverse fuel sources, including wind, run-of-river hydro, geothermal and gas-fired generation pl …
- Energir LP：企業の戦略的SWOT分析
Energir LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
- Energisa SA (ENGI11)：企業の財務・戦略的SWOT分析
Energisa SA (ENGI11) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
- RainDance Technologies Inc-製薬・医療分野：企業M&A・提携分析
Summary RainDance Technologies Inc (RDT) is a developer of genomic tools for non-invasive liquid biopsy applications. The company’s products include RainDrop Plus, a digital PCR system that provides picoliter droplets for multiplex detection of HIV and DNA. It also offers RainDrop Plus digital PCR s …
- Numaligarh Refinery Ltd：企業の戦略的SWOT分析
Numaligarh Refinery Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
- Pebblebrook Hotel Trust：企業の戦略・SWOT・財務情報
Pebblebrook Hotel Trust - Strategy, SWOT and Corporate Finance Report Summary Pebblebrook Hotel Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
- NovaBay Pharmaceuticals Inc (NBY)：医療機器：M&Aディール及び事業提携情報
Summary NovaBay Pharmaceuticals Inc (NovaBay), formerly NovaCal Pharmaceuticals Inc is a biopharmaceutical company that discovers and develops eyecare products. The company’s products include skin and wound cleanser, daily lid and lash hygiene spray solutions, and cosetic procedures. Its daily lid a …
- Stratos Product Development LLC-医療機器分野：企業M&A・提携分析
Summary Stratos Product Development LLC (Stratos) is a provider of product development solutions. The company offers medical product development, and product design and strategy services. It offers services which include product strategy, research, industrial design and interaction design. The compa …
- OceanaGold Corporation：企業の戦略・SWOT・財務情報
OceanaGold Corporation - Strategy, SWOT and Corporate Finance Report Summary OceanaGold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
- Living Cell Technologies Ltd (LCT)：製薬・医療：M&Aディール及び事業提携情報
Summary Living Cell Technologies Ltd (LCT) is a biotechnology company that develops cell-based therapeutics for the treatment of neurological diseases, diabetes, and stroke and hearing loss. It focuses on discovering regenerative treatments which restore function using naturally occurring cells. LCT …
- Microbiotix Inc-製薬・医療分野：企業M&A・提携分析
Summary Microbiotix Inc (Microbiotix) is a biopharmaceutical company that discovers and develops small molecule drugs for the treatment of infectious diseases. The company provides products for hepatitis C virus and human cytomegalovirus including HCV NS5B MBX-700, MBX-701 and MBX-400. It also provi …
- Salzgitter Klockner-Werke GmbH：企業の戦略・SWOT・財務情報
Salzgitter Klockner-Werke GmbH - Strategy, SWOT and Corporate Finance Report Summary Salzgitter Klockner-Werke GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
- Ecology and Environment Inc (EEI)：企業の財務・戦略的SWOT分析
Summary Ecology and Environment Inc (E&E) is an environmental consultancy service provider. The company provides air quality, cultural resources, emergency planning: mitigation and prevention, preparedness, and response and recovery, and water resources planning; climate and sustainable development; …
- HSBC Seguros de Vida Argentina S.A.：企業の戦略・SWOT・財務情報
HSBC Seguros de Vida Argentina S.A. - Strategy, SWOT and Corporate Finance Report Summary HSBC Seguros de Vida Argentina S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
- Agios Pharmaceuticals Inc (AGIO)：製薬・医療：M&Aディール及び事業提携情報
Summary Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company that focuses on the discovery and development of investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The company’s products include IDHIFA, an oral targeted inhibitor of the mutated IDH2 …
- Institute for Research in Immunology and Cancer-製薬・医療分野：企業M&A・提携分析
Summary Institute for Research in Immunology and Cancer (IRICoR), a subsidiary of University of Montreal is a non-profit research institute that offers drug discovery and commercialization services. The institute offers discovery, development and commercialization of novel drugs in oncology. It has …
- Merus NV (MRUS)：企業の財務・戦略的SWOT分析
Summary Merus NV (Merus) discovers and develops antibody therapeutics for cancer indications. The company is investigating MCLA-128, for the treatment of metastatic breast cancer and solid tumors; MCLA-117 designed to harness and activate T-cells to kill CLEC12A-expressing acute myeloid leukemia (AM …
- Cincinnati Bell Inc.：企業の戦略・SWOT・財務情報
Cincinnati Bell Inc. - Strategy, SWOT and Corporate Finance Report Summary Cincinnati Bell Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
- Whiting Petroleum Corporation：企業の戦略・SWOT・財務分析
Whiting Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary Whiting Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
- Spire Missouri Inc：石油・ガス：M&Aディール及び事業提携情報
Summary Spire Missouri Inc (Spire Missouri) formerly Laclede Gas Company, a subsidiary of Spire Inc, is an oil and gas company that distributes natural gas. The company offers natural gas appliances, commercial equipment and natural gas vehicles. It provides home sale inspection, repair and inspecti …